These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8100095)

  • 1. Brequinar Sodium: A New Immunosuppressive Drug for Transplantation. Symposium proceedings. Paris, France, August 16, 1992.
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):1-83. PubMed ID: 8100095
    [No Abstract]   [Full Text] [Related]  

  • 2. Brequinar sodium.
    Cramer DV
    Pediatr Nephrol; 1995; 9 Suppl():S52-5. PubMed ID: 7492488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of brequinar sodium for transplantation.
    Cramer DV; Chapman FA; Makowka L
    Ann N Y Acad Sci; 1993 Nov; 696():216-26. PubMed ID: 8109829
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of a new immunosuppressive drug, brequinar sodium, on concordant hamster-to-rat cardiac xenografts.
    Cramer DV; Chapman FA; Jaffee BD; Eiras-Hreha G; Yasunaga C; Wu GD; Makowka L
    Transplant Proc; 1992 Apr; 24(2):720-1. PubMed ID: 1566499
    [No Abstract]   [Full Text] [Related]  

  • 5. A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat.
    Knoop M; Cramer DV; Chapman FC; Makowka L
    Transplant Proc; 1993 Aug; 25(4):2697-8. PubMed ID: 8356719
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of liver allograft rejection in rats by a short course of therapy with Brequinar Sodium.
    Cramer DV; Knoop M; Chapman FA; Wa GD; Jaffee BD; Makowka L
    Transplantation; 1992 Oct; 54(4):752-3. PubMed ID: 1412774
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytidine potentiates the inhibitory effect of brequinar sodium on concordant cardiac xenograft rejection.
    Catena M; Woo J; Valdivia LA; Celli S; Pan F; Fung JJ; Starzl TE; Thompson AW
    Transplant Proc; 1994 Jun; 26(3):1288-9. PubMed ID: 8029911
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection.
    Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):57-8. PubMed ID: 8516945
    [No Abstract]   [Full Text] [Related]  

  • 9. Concentration-controlled immunosuppressive regimens using cyclosporine with sirolimus or brequinar in human renal transplantation.
    Kahan BD
    Transplant Proc; 1995 Feb; 27(1):33-6. PubMed ID: 7879019
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival.
    Cosenza CA; Cramer DV; Tuso PJ; Chapman FA; Wang HK; Makowka L
    J Heart Lung Transplant; 1994; 13(3):489-97. PubMed ID: 8061026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brequinar sodium effectively and potently suppresses allograft rejection in a heterotopic mouse heart transplant model.
    Murphy MP; Morris RE
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):75-6. PubMed ID: 7685955
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolonged xenograft survival following combination therapy with brequinar sodium and cyclosporine.
    Cosenza CA; Tuso PJ; Chapman FA; Middleton YD; Cramer DV; Wu GD; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):59-60. PubMed ID: 8516946
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of vascularized allograft and xenograft rejection in rodents by brequinar sodium.
    Cramer DV; Chapman FA; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):23-8. PubMed ID: 8516938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium.
    Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):65-6. PubMed ID: 8516948
    [No Abstract]   [Full Text] [Related]  

  • 15. Effective suppression of brequinar sodium on accelerated allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Ito A; Kuhara A; Nakata S; Shirakura R; Miyata M; Matsuda H
    Transplant Proc; 1995 Feb; 27(1):451-2. PubMed ID: 7879059
    [No Abstract]   [Full Text] [Related]  

  • 16. Synergistic effects of cyclosporin analogs--A, D, G, IMM-125--with rapamycin and/or brequinar.
    Kahan BD; Chou T; Tejpal N; Wang M; Chee C; Stepkowski S
    Transplant Proc; 1994 Oct; 26(5):3021-4. PubMed ID: 7940951
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
    Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Yamamoto S; Nakata S; Shirakura R; Miyata M; Matsuda H; Stepkowski SM
    Transplant Proc; 1994 Aug; 26(4):2333-5. PubMed ID: 7520633
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation of the in vitro and in vivo immunosuppressive activity of brequinar sodium.
    Eiras-Hreha G; Cramer DV; Cajulis E; Cosenza C; Mills L; Hough K; Frankland M; Chapman F; Wang H; Zajac I
    Transplant Proc; 1993 Feb; 25(1 Pt 1):708-9. PubMed ID: 8438448
    [No Abstract]   [Full Text] [Related]  

  • 20. Triple combination of cyclosporine, brequinar, and rapamycin prolongs kidney allograft survival in the mongrel dog.
    Ferraresso M; Knight R; Tu Y; Stepkowski SM; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3028. PubMed ID: 7940953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.